Protara Therapeutics Inc expected to post a loss of 80 cents a share - Earnings Preview

Protara Therapeutics

30/07/2024 19:37

* Protara Therapeutics Inc  TARA.OQ   TARA.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 1 (estimated) for the period ending June 30 2024
    * 
    * ​LSEG's mean analyst estimate for Protara Therapeutics Inc
is
for a loss of 80 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Protara
Therapeutics Inc is $23.00​, above​ its last closing price
of $2.31. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.86       -0.92      -0.97     Missed  -5.4
 Dec. 31 2024              -0.92      -0.90     Beat    1.9
 Sep. 30 2023  -1.04       -0.98      -0.87     Beat    11.2​
 Jun. 30 2023  -0.88       -0.87      -1.00     Missed  -14.3
 ​​Mar.        -0.91       -0.88      -0.80     Beat    8.8
 31 2023                                                
 Dec. 31 2022              -0.75      -1.55     Missed  -106.7
                                                        ​
 Sep. 30 2022  -0.77       -0.76      -0.68     Beat    10.1
 Jun. 30 2022  -1.02       -0.94      -0.80     Beat    14.6
 This summary was machine generated July 30 at 18:37 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)